Provera vs. Bijuve
See how Provera and Bijuve compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Provera is a progestin-only tablet used to treat abnormal uterine bleeding, secondary amenorrhea, and to protect the uterus during estrogen therapy, while Bijuve is a combination capsule made specifically for hot flashes.
Bijuve pairs bioidentical estradiol and progesterone in one daily capsule to relieve moderate to severe menopausal hot flashes, something Provera alone does not do.
Provera has decades of clinical use and a much lower monthly cost, while Bijuve is newer and priced several times higher.
Provera vs. Bijuve Drug Summary
Provera
Provera (medroxyprogesterone acetate) is a synthetic progestin tablet approved in 1959 to treat secondary amenorrhea and abnormal uterine bleeding caused by hormonal imbalance. It is also used alongside daily estrogen therapy to prevent endometrial hyperplasia in postmenopausal women. It is taken orally, usually for 5 to 10 days depending on the condition being treated.
Bijuve
Bijuve (estradiol and progesterone) is a combination hormone capsule approved in 2018 to treat moderate to severe hot flashes from menopause. It is meant for women who still have a uterus, pairing estrogen with progesterone to protect the uterine lining. It is taken as one capsule by mouth once a day.
Provera vs. Bijuve Side Effects
Provera
Bijuve
Provera vs. Bijuve Dosage
Provera
Bijuve
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg or 10 mg daily | At the start |
| Maximum dose | 10 mg daily | If needed |
| Dose changes | 1 increase | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg/100 mg once daily | At the start |
| Maximum dose | 1 mg/100 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Provera
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg or 10 mg daily | At the start |
| Maximum dose | 10 mg daily | If needed |
| Dose changes | 1 increase | As tolerated |
Bijuve
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg/100 mg once daily | At the start |
| Maximum dose | 1 mg/100 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Provera vs. Bijuve Indications
Provera
Provera is FDA-approved to treat secondary amenorrhea and abnormal uterine bleeding caused by hormonal imbalance. It is also used alongside daily estrogen therapy to prevent endometrial hyperplasia in postmenopausal women who have not had a hysterectomy. It is not approved as a standalone contraceptive.
Secondary amenorrhea treatment
Abnormal uterine bleeding management
Endometrial hyperplasia prevention with estrogen
Not approved as a standalone contraceptive
Bijuve
Bijuve is FDA-approved to treat moderate to severe hot flashes caused by menopause in women who still have a uterus. The progesterone component protects the uterine lining from the effects of the estrogen included in the same capsule. It is not approved for women without a uterus.
Moderate to severe hot flash relief
For women with an intact uterus
Protects uterine lining from estrogen effects
Not approved for women without a uterus
Provera vs. Bijuve Pros and Cons
Provera
Provera has been available since 1959, giving it a long track record and a low cost, typically $15 to $75 per month. It only contains progestin, so it does not address hot flashes on its own and is often paired with a separate estrogen product. It is a widely prescribed generic with broad insurance coverage.
Pros
Long track record dating back to 1959
Roughly $15 to $75 per month, much lower cost than Bijuve
Available in three tablet strengths for flexible dosing
Cons
Does not treat hot flashes on its own
Requires pairing with separate estrogen for menopause symptoms
Side effect rates not clearly quantified in the label
Boxed warning when combined with estrogen therapy
Bijuve
Bijuve combines bioidentical estradiol and progesterone in one capsule, offering a simpler regimen for treating hot flashes. It typically costs $257 to $351 per month, well above Provera's price range. As a newer drug approved in 2018, it has less long-term real-world experience behind it.
Pros
Combines estrogen and progesterone in a single daily capsule
FDA-approved specifically for menopausal hot flashes
Bioidentical hormone formulation
Cons
Roughly $257 to $351 per month, several times costlier than Provera
Boxed warnings for cardiovascular events, dementia, and cancer risks
Not approved for women without a uterus
Less long-term usage history since approval in 2018
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.